Pia Lading

Title: **Pia Lading: Innovator in Controlled Delivery Systems**

Introduction

Pia Lading, a talented inventor based in Gentofte, Denmark, has made significant strides in the field of controlled delivery of biologically active agents. With her innovative approach, she has contributed to improving treatments for various medical conditions, particularly periodontal disease.

Latest Patents

Lading holds a patent for a groundbreaking method and composition for controlled delivery of biologically active agents. This method combines a monoglyceride and a vegetable oil to create a composition that, upon contact with an aqueous liquid, forms a reverse hexagonal liquid crystalline phase matrix. This matrix is designed to release the active agent in a controlled fashion, making it particularly useful for treating periodontal disease. The innovation allows for direct insertion of the liquid crystalline phase precursor composition into the periodontal pocket, where water from the gingival fluid induces the spontaneous in situ formation of the matrix, enhancing the efficacy of the treatment.

Career Highlights

Pia Lading is associated with A/S Dumex, where she has been instrumental in developing her patent. Her work focuses on the intricacies of drug delivery systems, showcasing her commitment to advancing medical solutions through inventive methodologies. Over her career, she has worked on various projects that harness the potential of biologically active agents in healthcare.

Collaborations

During her tenure at A/S Dumex, Lading has collaborated with esteemed colleagues including Yvonne Lundsholm and Tomas Norling. These collaborations have facilitated a productive exchange of ideas and expertise, further enriching the innovation process and leading to advancements in their field.

Conclusion

Pia Lading exemplifies the spirit of innovation within the medical field. With her patented method for controlled delivery of biologically active agents, she continues to contribute to significant improvements in health treatments. Her work at A/S Dumex, coupled with collaborative efforts with her team, underscores the importance of collaborative innovation in addressing complex medical challenges.